We didn’t wait for the next advance against cancer. We created it.
Learn why our CSO, Nick Keen, is #NotWaiting.
We didn’t wait for the next advance against cancer. We created it.
Learn why our U.K. team is #NotWaiting.
View all news

News

18 March 2019
Bicycle Therapeutics Appoints Pierre Legault as New Director and Board Chairman

Social Media

@Bicycle_tx Mar 19
Bicycle is thrilled to welcome biopharma executive Terry West, who joins the team as VP, Head of Program Management… http://s1qO0VJMRv

Our Programs

We are focused on developing three categories of Bicycles against our oncology targets:

Bicycle Toxin ConjugatesBicycle Targeted Innate Immune ActivatorsBicycle T-Cell Modulators

Our Technology

Learn about our revolutionary Bicycle technology

Beyond Oncology

Bicycle programs outside of cancer